Antoni Wiedlocha funded by the EEA Poland-Norway grants
Antoni Wiedlocha
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Bretthauer M, Ahmed J, Antonelli G, Beaumont H, Beg S, Benson A, Bisschops R, De Cristofaro E, Gibbons E, Häfner M, Karsenti D, Laquière A, Loly JP, O'Reilly SM, Pellisé M, Grubelic Ravic K, Triantafyllou K, Tziatzios G, Valente R, Walter BM, Wiesand M, Lorenzo-Zúñiga V, Gralnek IM(2025) Use of computer-assisted detection (CADe) colonoscopy in colorectal cancer screening and surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement Endoscopy(in press) DOI 10.1055/a-2543-0370, PubMed 40148135
Atar D, Vandenbriele C, Agewall S, Gigante B, Goette A, Gorog DA, Holme PA, Krychtiuk KA, Rocca B, Siller-Matula JM, Valgimigli M, Rubboli A, Klamroth R(2025) Management of patients with congenital bleeding disorders and cardiac indications for antithrombotic therapy Eur Heart J Cardiovasc Pharmacother(in press) DOI 10.1093/ehjcvp/pvaf006, PubMed 40145128
Olstad EW, Nordeng H, Bjørk MH, Selmer KK, Gervin K(2025) Agreement Between Parental Self-Reported Antiseizure Medication Use and Dispensed Prescription Records From a National Prescription Database Pharmacoepidemiol Drug Saf, 34(4), e70139 DOI 10.1002/pds.70139, PubMed 40134051